Quick answer
What should be verified when sourcing a GLOW-type blend? Check each of the three components separately: identity by mass for GHK, BPC-157 and TB-500, a resolved HPLC trace with three labelled peaks, and a ratio calibrated against reference standards, because raw peak areas do not equal mass. Copper needs its own elemental test; roughly 15.7% of the GHK-Cu mass is expected for a one-to-one complex. Request a lot-specific certificate with a result per component, and keep the vial at 2–8 °C, or −20 °C for long-term. For laboratory research use only.
A three-peptide blend is harder to verify than a single compound. A certificate that says "purity 98%" can describe one component well and the other two not at all. This guide is a verification checklist for laboratories sourcing a GLOW-type blend of GHK-Cu, BPC-157 and TB-500 for research: what to confirm about each component, how to check the ratio, why copper content needs its own test, which documents to request and how to judge storage and handling claims. It does not rank suppliers or make any claim about outcomes. The material is for laboratory research use only; not for human consumption. General principles are in how to buy research peptides online and vetting a research peptide supplier; this article adds what is specific to blends.
Start from the specification
Write down what the label and product page claim, so that every document can be compared against it. The V8 GLOW stack product page lists a 70 mg total vial with GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg, supplied as a co-lyophilized powder in a sealed clear glass research vial, purity stated as ≥98% by HPLC, storage at 2–8 °C, or −20 °C for long-term, with protection from heat, moisture and light. The page states that sequence and identity are reported on the certificate of analysis where published. Any supplier's claim should reduce to a similar list: components, masses, form, purity method, storage.
What can go wrong with a blend
| Failure mode | How it happens | What reveals it |
|---|---|---|
| --- | --- | --- |
| A component missing or under-represented | Weighing or transfer error, or a component that failed in synthesis | Component-resolved HPLC with mass identification of each peak |
| Wrong ratio | Blending error | Peak areas or quantification against standards per component |
| Copper content off | Incomplete complexation, free copper, or copper loss | Elemental analysis (for example ICP-MS or atomic absorption) |
| Mislabelled total | Total mass equals the sum of the parts only on paper | Mass balance and net peptide content |
| Cross-reaction on storage | Copper catalyzes oxidation of the other peptides | Time-course HPLC; see the stability article on copper in blends |
| Cosmetic inconsistency | Wrong color or cake appearance | Visual receiving inspection |
The distinction from a single-compound vial is that the failure can be partial. A single-peptide vial is either mostly right or mostly wrong; a blend can be right for two of three components.
Verifying each component
GHK-Cu
GHK is the tripeptide glycyl-L-histidyl-L-lysine, which binds copper(II) as described by Pickart and colleagues (1980). The complex is intensely blue, which is why the lyophilized cake and the reconstituted solution of the blend are blue; the colour comes from the copper complex and is expected. Identity of the peptide part is shown by mass; the copper part by elemental analysis. The peptide alone has a mass near 340 g/mol and the complex near 404 g/mol, so a mass spectrum may show both forms depending on conditions. GHK-Cu purity testing goes through the analytical detail.
BPC-157
BPC-157 is a 15-residue peptide with a published sequence, and its molecular weight is about 1,419.5 g/mol. Its three consecutive prolines make it a distinctive chromatographic and mass-spectrometric target. Identity should be shown by observed mass against theoretical mass. BPC-157 purity testing covers the method.
TB-500
The TB-500 in a blend is described as a short N-acetylated fragment of thymosin beta-4 with a molecular weight near 889 g/mol. A supplier that supplies the full 43-residue thymosin beta-4 under this name has supplied a different material, so check the observed mass. TB-500 purity testing and TB-500 versus thymosin beta-4 explain what to expect.
Verifying the ratio
The nominal ratio is 5:1:1 by mass, but chromatography reports relative absorbance, not mass, and the three components absorb differently. Peptide-bond absorbance at 214 nm scales roughly with the number of bonds, so a seven-residue peptide and a fifteen-residue peptide at equal mass give similar but not identical areas, while the copper complex of a tripeptide absorbs differently again because of the metal-to-ligand transitions. Reading the ratio from raw peak areas is therefore unreliable. The reliable approach is to calibrate each component against its own reference standard of known concentration, which gives mass per component directly. Few suppliers publish this, and a laboratory that needs the ratio to be right should either request it or do the calibration itself. The arithmetic after calibration is simple: component mass divided by the diluent volume gives each concentration, and the reconstitution calculator is there for the nominal figures.
Why copper needs its own test
Peptide HPLC does not measure copper. Elemental techniques such as ICP-MS or atomic absorption do. For a GHK-Cu product the copper content should be consistent with a one-to-one complex of the GHK present: roughly 63.5 g of copper per 404 g of complex, about 15.7% of the GHK-Cu mass by that arithmetic. A copper value well above this suggests free copper, which is more reactive and more likely to affect the other peptides; a value well below suggests incomplete complexation. Whether a given supplier reports copper is itself informative. Copper is also the reason for caution about storage, since transition metals can promote oxidation of susceptible residues; does copper degrade other peptides in a blend discusses it.
Documents to request
| Document | What it should show for a blend |
|---|---|
| --- | --- |
| Certificate of analysis | Lot number, test date, and results for each of the three components, not one combined figure |
| HPLC chromatogram | Three resolved peaks with labels, method and wavelength |
| Mass data | Observed against theoretical masses for each peptide |
| Copper result | A value from an elemental method, with the method named |
| Specification | Per-component masses, form, storage and container |
The COA library lists certificates where published, and how to read a COA explains the fields. A certificate that reports only a combined purity for a three-component product answers less than half of the questions above.
Storage and handling claims
Look at what the supplier says about temperature, light and moisture, and whether the statement is consistent across label, page and certificate. The V8 page's tiers of 2–8 °C and −20 °C are the ones to carry into the laboratory. Keep the sealed vial cold and dry, let it reach room temperature before opening, and record lot and date. Handling after dissolution is covered in glow peptide reconstitution and storage. Claims of indefinite stability at room temperature should be treated as unsupported unless data are given; the general principles of protein pharmaceutical stability (Manning and colleagues, 2010) explain why.
Keeping a reference lot
Once a lot passes verification, keep a small sealed portion of it, or a frozen reference solution, as a comparator. When the next lot arrives, run both on the same chromatographic method on the same day. A shift in retention time, a change in the relative size of the three peaks or a new peak in the new lot is visible immediately against the reference, and no certificate comparison is needed. This simple habit is the cheapest form of lot-to-lot quality control a small laboratory can run, and it works for blends because each of the three peaks has its own history.
Receiving inspection
On arrival, check the closure and seal, look at the cake, and record the color. A blue to blue-green cake is expected for this blend; a brown, black or colorless cake is not. Note whether the cake is intact or broken up; the latter is cosmetic. Photograph the vial next to its label, record the lot, and file the certificate with the study notes. For general appearance guidance see peptide vial appearance: what is normal.
When a single-component purchase is the better choice
If the experiment varies the ratio, if any one component is the actual subject, or if the verification above cannot be completed for a blend, buying the components separately is simpler to verify: each vial needs one identity result and one purity figure. The product pages for GHK-Cu, BPC-157 and TB-500 list the supplied sizes. The trade-offs are discussed in GLOW stack vs individual peptides.
Frequently asked questions
Why is a blend harder to verify than a single peptide?
It can be partly right. One component may be under-represented or missing while the others look fine, and a combined purity figure can conceal that. Each component needs its own identity and quantity result.
What is the blend ratio?
The V8 GLOW stack lists GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg per 70 mg vial, a 5:1:1 mass ratio, which is roughly 17.6 : 1 : 1.6 by moles using approximate molecular weights.
Can the ratio be read from HPLC peak areas?
Not reliably. Peak area reflects absorbance, and the three components absorb differently. Calibration against a reference standard for each component gives mass directly.
Why does copper content need a separate test?
HPLC measures peptides, not metals. Elemental methods such as ICP-MS measure copper. Roughly 15.7% of the GHK-Cu mass is copper for a one-to-one complex, so a value far from that suggests a problem.
Why is the blend blue?
The copper(II) complex of GHK is intensely blue, so the lyophilized cake and the reconstituted solution are blue. The color is expected for this material.
What mass should TB-500 show?
About 889 g/mol for the short N-acetylated fragment. A much larger mass would indicate the full thymosin beta-4 protein, which is a different material.
What documents should accompany the vial?
A lot-specific certificate with a result per component, the chromatogram, mass data, a copper result with the method named, and a specification with per-component masses and storage.
What are the storage tiers on the V8 product page?
Refrigerate at 2–8 °C, use −20 °C for long-term, and protect from heat, moisture and light.
When are separate vials easier to verify?
When the ratio is a variable, when one component is the subject, or when the blend cannot be verified per component. Each single vial then needs one identity result and one purity figure.
Related reading: GLOW Stack Research Protocol: Lab Workflow and Models, GLOW Stack vs Individual Peptides: Study Rationale.
References
- Pickart L, Freedman JH, Loker WJ, et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980;288(5792):715-717. doi:10.1038/288715a0
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Goldstein AL, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51. doi:10.1517/14712598.2012.634793
- Seiwerth S, Brcic L, Vuletic LB, et al. BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr Pharm Des. 2018;24(18):1972-1989. doi:10.2174/1381612824666180712110447
